Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Related CRS and ICANS - A Multicenter Retrospective Analysis.
Bajwa A, Zhao Q, Geer MJ, Lin C, Westholder J, Maakaron J, Ghosh M, Frame DG, Galal A, Tossey J, Ahmed N, Bezerra ED, Denlinger N, de Lima MJ, Epperla N, Caimi PF, Voorhees TJ.
Bajwa A, et al.
Blood Adv. 2024 Oct 22:bloodadvances.2024013688. doi: 10.1182/bloodadvances.2024013688. Online ahead of print.
Blood Adv. 2024.
PMID: 39437770